- Home
- BTAI vs UPLD Comparison
BTAI vs UPLD Comparison
Compare BTAI & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- UPLD
- Stock Information
- Founded
- BTAI 2017
- UPLD 2010
- Country
- BTAI United States
- UPLD United States
- Employees
- BTAI 37
- UPLD N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- UPLD Computer Software: Prepackaged Software
- Sector
- BTAI Health Care
- UPLD Technology
- Exchange
- BTAI Nasdaq
- UPLD Nasdaq
- Market Cap
- BTAI 41.8M
- UPLD 52.0M
- IPO Year
- BTAI 2018
- UPLD 2014
- Fundamental
- Price
- BTAI $2.12
- UPLD $1.85
- Analyst Decision
- BTAI Buy
- UPLD Strong Buy
- Analyst Count
- BTAI 5
- UPLD 1
- Target Price
- BTAI $32.80
- UPLD $4.50
- AVG Volume (30 Days)
- BTAI 691.3K
- UPLD 172.9K
- Earning Date
- BTAI 11-12-2025
- UPLD 11-06-2025
- Dividend Yield
- BTAI N/A
- UPLD N/A
- EPS Growth
- BTAI N/A
- UPLD N/A
- EPS
- BTAI N/A
- UPLD N/A
- Revenue
- BTAI $752,000.00
- UPLD $235,591,000.00
- Revenue This Year
- BTAI N/A
- UPLD N/A
- Revenue Next Year
- BTAI $544.99
- UPLD N/A
- P/E Ratio
- BTAI N/A
- UPLD N/A
- Revenue Growth
- BTAI N/A
- UPLD N/A
- 52 Week Low
- BTAI $1.17
- UPLD $1.62
- 52 Week High
- BTAI $9.26
- UPLD $5.64
- Technical
- Relative Strength Index (RSI)
- BTAI 54.12
- UPLD 41.56
- Support Level
- BTAI $1.72
- UPLD $1.79
- Resistance Level
- BTAI $2.09
- UPLD $1.93
- Average True Range (ATR)
- BTAI 0.18
- UPLD 0.13
- MACD
- BTAI 0.06
- UPLD 0.02
- Stochastic Oscillator
- BTAI 98.36
- UPLD 61.71
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.